Thomas Kelly Jr
Concepts (441)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Schizosaccharomyces | 6 | 2019 | 60 | 1.960 |
Why?
| Serine Endopeptidases | 11 | 2016 | 50 | 1.910 |
Why?
| Gelatinases | 11 | 2016 | 32 | 1.900 |
Why?
| Membrane Proteins | 16 | 2023 | 335 | 1.750 |
Why?
| Breast Neoplasms | 14 | 2024 | 1212 | 1.410 |
Why?
| DNA Replication | 6 | 2019 | 160 | 1.340 |
Why?
| Cricetulus | 1 | 2024 | 104 | 0.870 |
Why?
| Neoplasm Invasiveness | 9 | 2016 | 278 | 0.870 |
Why?
| Glucuronidase | 5 | 2010 | 47 | 0.830 |
Why?
| Students, Medical | 1 | 2023 | 159 | 0.730 |
Why?
| Eukaryotic Cells | 2 | 2019 | 15 | 0.670 |
Why?
| Propylene Glycol | 1 | 2018 | 1 | 0.610 |
Why?
| Glycerol | 1 | 2018 | 19 | 0.610 |
Why?
| Animals | 35 | 2024 | 13505 | 0.600 |
Why?
| DNA Damage | 3 | 2016 | 305 | 0.570 |
Why?
| Neoplasms | 4 | 2023 | 1325 | 0.570 |
Why?
| DNA, Fungal | 2 | 2016 | 43 | 0.560 |
Why?
| Neoplasm Metastasis | 8 | 2011 | 243 | 0.560 |
Why?
| Endopeptidases | 13 | 2016 | 66 | 0.560 |
Why?
| Biomedical Research | 2 | 2014 | 256 | 0.550 |
Why?
| Cocaine | 3 | 2023 | 177 | 0.540 |
Why?
| Ultraviolet Rays | 2 | 2007 | 50 | 0.530 |
Why?
| Body Composition | 3 | 2023 | 338 | 0.530 |
Why?
| Adenocarcinoma | 3 | 2005 | 405 | 0.530 |
Why?
| DNA Repair | 2 | 2016 | 195 | 0.510 |
Why?
| G2 Phase Cell Cycle Checkpoints | 1 | 2016 | 9 | 0.500 |
Why?
| Gene Expression Regulation, Fungal | 1 | 2016 | 51 | 0.490 |
Why?
| Humans | 55 | 2024 | 52483 | 0.490 |
Why?
| Schizosaccharomyces pombe Proteins | 5 | 2019 | 43 | 0.480 |
Why?
| Smoking | 1 | 2018 | 520 | 0.460 |
Why?
| Origin Recognition Complex | 2 | 2019 | 6 | 0.460 |
Why?
| Proteoglycans | 5 | 2023 | 87 | 0.450 |
Why?
| Extracellular Matrix | 6 | 2005 | 112 | 0.440 |
Why?
| Syndecan-1 | 4 | 2010 | 74 | 0.440 |
Why?
| Medical Oncology | 2 | 2023 | 104 | 0.430 |
Why?
| Cell Movement | 4 | 2019 | 268 | 0.420 |
Why?
| Body Water | 2 | 2023 | 27 | 0.410 |
Why?
| Cell Line, Tumor | 10 | 2020 | 1470 | 0.410 |
Why?
| Mice | 13 | 2023 | 5949 | 0.380 |
Why?
| Disease | 1 | 2012 | 24 | 0.380 |
Why?
| Cellular Microenvironment | 1 | 2012 | 30 | 0.370 |
Why?
| Cell Membrane | 9 | 2005 | 245 | 0.360 |
Why?
| Dopaminergic Neurons | 4 | 2023 | 19 | 0.360 |
Why?
| Cell Cycle Proteins | 3 | 2020 | 169 | 0.350 |
Why?
| Female | 27 | 2024 | 28171 | 0.350 |
Why?
| Vulvar Neoplasms | 3 | 2016 | 60 | 0.350 |
Why?
| Antigens, Neoplasm | 2 | 2011 | 147 | 0.350 |
Why?
| Fructose | 1 | 2010 | 22 | 0.350 |
Why?
| Dipeptidyl Peptidase 4 | 3 | 2011 | 10 | 0.340 |
Why?
| Carbon | 1 | 2010 | 55 | 0.340 |
Why?
| Stromal Cells | 3 | 2016 | 79 | 0.340 |
Why?
| Cytoskeletal Proteins | 3 | 2020 | 48 | 0.320 |
Why?
| Transfection | 4 | 2024 | 357 | 0.320 |
Why?
| Neovascularization, Pathologic | 3 | 2005 | 153 | 0.310 |
Why?
| Membrane Glycoproteins | 6 | 2005 | 244 | 0.310 |
Why?
| Cell Cycle | 2 | 2007 | 230 | 0.300 |
Why?
| Multiple Myeloma | 6 | 2004 | 3049 | 0.300 |
Why?
| Bone and Bones | 2 | 2010 | 494 | 0.300 |
Why?
| Carcinoma, Squamous Cell | 3 | 2016 | 332 | 0.300 |
Why?
| Heparan Sulfate Proteoglycans | 2 | 2005 | 12 | 0.290 |
Why?
| Mammary Neoplasms, Experimental | 2 | 2005 | 122 | 0.280 |
Why?
| Osteogenesis | 1 | 2010 | 366 | 0.280 |
Why?
| Tumor Cells, Cultured | 7 | 2010 | 460 | 0.280 |
Why?
| Bone Resorption | 2 | 2010 | 302 | 0.270 |
Why?
| Cell Adhesion | 7 | 2020 | 163 | 0.270 |
Why?
| Osteoclasts | 1 | 2010 | 428 | 0.270 |
Why?
| RNA, Messenger | 4 | 2023 | 1132 | 0.270 |
Why?
| Bone Neoplasms | 2 | 2005 | 184 | 0.250 |
Why?
| Mice, SCID | 4 | 2010 | 182 | 0.250 |
Why?
| Oligosaccharides | 1 | 2005 | 34 | 0.250 |
Why?
| Antibodies, Neoplasm | 1 | 2005 | 28 | 0.240 |
Why?
| Models, Biological | 4 | 2019 | 735 | 0.240 |
Why?
| Peripheral Nerves | 2 | 2015 | 44 | 0.240 |
Why?
| DNA | 1 | 2008 | 549 | 0.240 |
Why?
| Nanostructures | 1 | 2005 | 48 | 0.230 |
Why?
| Education, Medical, Undergraduate | 1 | 2006 | 85 | 0.230 |
Why?
| Pseudohypoaldosteronism | 1 | 2024 | 7 | 0.230 |
Why?
| Receptors, Mineralocorticoid | 1 | 2024 | 12 | 0.230 |
Why?
| Gene Expression Regulation, Neoplastic | 3 | 2019 | 857 | 0.220 |
Why?
| Clone Cells | 1 | 2024 | 77 | 0.220 |
Why?
| CHO Cells | 1 | 2024 | 125 | 0.220 |
Why?
| Drug Industry | 1 | 2024 | 40 | 0.220 |
Why?
| Extinction, Psychological | 1 | 2023 | 34 | 0.210 |
Why?
| Metalloendopeptidases | 3 | 1998 | 69 | 0.210 |
Why?
| gamma-Aminobutyric Acid | 1 | 2023 | 62 | 0.210 |
Why?
| Research | 1 | 2023 | 107 | 0.210 |
Why?
| Actins | 5 | 2020 | 115 | 0.200 |
Why?
| Fear | 1 | 2023 | 82 | 0.200 |
Why?
| Phosphorylation | 4 | 2020 | 528 | 0.200 |
Why?
| Serotonin | 1 | 2023 | 146 | 0.200 |
Why?
| Cell Proliferation | 5 | 2019 | 1023 | 0.190 |
Why?
| Macrophages | 2 | 2016 | 379 | 0.190 |
Why?
| Parkinson Disease, Secondary | 1 | 2021 | 6 | 0.190 |
Why?
| Program Evaluation | 1 | 2023 | 353 | 0.190 |
Why?
| Pyrans | 1 | 2021 | 16 | 0.190 |
Why?
| Drug-Seeking Behavior | 1 | 2021 | 5 | 0.190 |
Why?
| Phosphodiesterase Inhibitors | 1 | 2021 | 24 | 0.190 |
Why?
| Telomerase | 1 | 2021 | 26 | 0.190 |
Why?
| Reinforcement Schedule | 1 | 2021 | 71 | 0.180 |
Why?
| Bone Density | 1 | 2023 | 399 | 0.180 |
Why?
| Cues | 1 | 2021 | 52 | 0.180 |
Why?
| Collagenases | 2 | 1999 | 24 | 0.180 |
Why?
| Receptor, Cannabinoid, CB2 | 1 | 2021 | 57 | 0.180 |
Why?
| Neoplasm Proteins | 4 | 1998 | 334 | 0.180 |
Why?
| Internal Mammary-Coronary Artery Anastomosis | 1 | 2020 | 5 | 0.180 |
Why?
| Curriculum | 1 | 2023 | 398 | 0.170 |
Why?
| Radial Artery | 1 | 2020 | 34 | 0.170 |
Why?
| Pyrimidines | 1 | 2021 | 199 | 0.170 |
Why?
| Pyridines | 1 | 2021 | 132 | 0.170 |
Why?
| Behavior, Animal | 1 | 2021 | 185 | 0.170 |
Why?
| Collagen Type I | 2 | 2016 | 83 | 0.170 |
Why?
| Saccharomyces cerevisiae Proteins | 1 | 2021 | 139 | 0.170 |
Why?
| Neurons | 1 | 2023 | 418 | 0.170 |
Why?
| Cyclin-Dependent Kinase 5 | 1 | 2020 | 1 | 0.170 |
Why?
| Matrix Metalloproteinases | 1 | 2000 | 47 | 0.170 |
Why?
| Actin Cytoskeleton | 1 | 2020 | 22 | 0.170 |
Why?
| Signal Transduction | 7 | 2020 | 1671 | 0.160 |
Why?
| Immunohistochemistry | 5 | 2016 | 979 | 0.160 |
Why?
| Cyclic AMP | 1 | 2020 | 91 | 0.160 |
Why?
| Parkinson Disease | 1 | 2021 | 155 | 0.160 |
Why?
| Cocaine-Related Disorders | 1 | 2021 | 207 | 0.160 |
Why?
| Lung Neoplasms | 1 | 2005 | 636 | 0.160 |
Why?
| Electric Impedance | 3 | 2023 | 49 | 0.160 |
Why?
| AT Rich Sequence | 1 | 2019 | 1 | 0.160 |
Why?
| DNA Replication Timing | 1 | 2019 | 1 | 0.160 |
Why?
| DNA-Directed RNA Polymerases | 1 | 2019 | 12 | 0.160 |
Why?
| Chromosomes, Fungal | 1 | 2019 | 13 | 0.160 |
Why?
| Genome, Fungal | 1 | 2019 | 29 | 0.150 |
Why?
| Pharmaceutical Solutions | 1 | 2018 | 9 | 0.150 |
Why?
| Cell Division | 3 | 2004 | 291 | 0.150 |
Why?
| Sensation | 1 | 2018 | 11 | 0.150 |
Why?
| Pancreas | 1 | 2019 | 71 | 0.150 |
Why?
| Stimulation, Chemical | 1 | 2018 | 27 | 0.150 |
Why?
| Drug Compounding | 1 | 2018 | 28 | 0.150 |
Why?
| Ventral Tegmental Area | 3 | 2023 | 8 | 0.150 |
Why?
| Probability | 1 | 2019 | 172 | 0.150 |
Why?
| Plants | 1 | 2018 | 30 | 0.150 |
Why?
| Male | 10 | 2024 | 26761 | 0.150 |
Why?
| Aerosols | 1 | 2018 | 75 | 0.150 |
Why?
| Mice, Inbred BALB C | 2 | 2011 | 312 | 0.140 |
Why?
| Cell Transformation, Neoplastic | 1 | 2019 | 184 | 0.140 |
Why?
| Protein Processing, Post-Translational | 1 | 2019 | 153 | 0.140 |
Why?
| Computer Simulation | 1 | 2019 | 290 | 0.140 |
Why?
| Carcinoma, Ductal, Breast | 1 | 1998 | 90 | 0.140 |
Why?
| Phenotype | 3 | 2010 | 789 | 0.140 |
Why?
| Catalytic Domain | 2 | 2009 | 60 | 0.140 |
Why?
| Adult | 9 | 2023 | 14161 | 0.140 |
Why?
| Transcription, Genetic | 1 | 2019 | 378 | 0.140 |
Why?
| Isotonic Solutions | 1 | 2017 | 20 | 0.140 |
Why?
| Young Adult | 4 | 2023 | 4329 | 0.130 |
Why?
| Coronary Artery Disease | 1 | 2020 | 294 | 0.130 |
Why?
| Fluid Therapy | 1 | 2017 | 78 | 0.130 |
Why?
| Pancreatitis | 1 | 2017 | 64 | 0.130 |
Why?
| Time-Lapse Imaging | 1 | 2016 | 3 | 0.130 |
Why?
| Secretory Leukocyte Peptidase Inhibitor | 1 | 2015 | 1 | 0.130 |
Why?
| Blood Pressure | 1 | 2018 | 537 | 0.130 |
Why?
| Rad51 Recombinase | 1 | 2016 | 25 | 0.130 |
Why?
| Nucleotidyltransferases | 1 | 2016 | 14 | 0.120 |
Why?
| Epithelial-Mesenchymal Transition | 1 | 2016 | 57 | 0.120 |
Why?
| Simplexvirus | 1 | 2015 | 15 | 0.120 |
Why?
| Scavenger Receptors, Class A | 1 | 2016 | 39 | 0.120 |
Why?
| Protein Kinases | 2 | 2006 | 72 | 0.120 |
Why?
| Virus Internalization | 1 | 2015 | 20 | 0.120 |
Why?
| Mitosis | 1 | 2016 | 88 | 0.120 |
Why?
| Cell Transformation, Viral | 3 | 1994 | 25 | 0.120 |
Why?
| Human papillomavirus 16 | 1 | 2015 | 44 | 0.120 |
Why?
| Fibroma | 1 | 2015 | 40 | 0.120 |
Why?
| Syndecans | 4 | 2005 | 37 | 0.120 |
Why?
| Keratinocytes | 1 | 2015 | 93 | 0.120 |
Why?
| Models, Organizational | 1 | 2015 | 58 | 0.120 |
Why?
| Avian Sarcoma Viruses | 2 | 1994 | 5 | 0.120 |
Why?
| Enzyme Activation | 3 | 2006 | 270 | 0.120 |
Why?
| DNA-Directed DNA Polymerase | 1 | 2016 | 89 | 0.120 |
Why?
| Neoplasm Transplantation | 2 | 2005 | 87 | 0.120 |
Why?
| Transplantation, Heterologous | 2 | 2005 | 79 | 0.110 |
Why?
| Fibroblasts | 3 | 1994 | 355 | 0.110 |
Why?
| Extracellular Matrix Proteins | 2 | 1994 | 69 | 0.110 |
Why?
| Neoplasm Recurrence, Local | 2 | 2015 | 649 | 0.110 |
Why?
| Recombinant Proteins | 3 | 2016 | 483 | 0.110 |
Why?
| Multiprotein Complexes | 1 | 2014 | 25 | 0.110 |
Why?
| Host-Pathogen Interactions | 1 | 2015 | 144 | 0.110 |
Why?
| Ubiquitination | 1 | 2014 | 47 | 0.110 |
Why?
| Community Pharmacy Services | 1 | 2015 | 68 | 0.110 |
Why?
| Peptide Hydrolases | 2 | 1994 | 63 | 0.110 |
Why?
| Inflammasomes | 1 | 2014 | 66 | 0.110 |
Why?
| Cytoskeleton | 3 | 1989 | 39 | 0.100 |
Why?
| Immunity, Innate | 1 | 2014 | 117 | 0.100 |
Why?
| Absorptiometry, Photon | 2 | 2023 | 162 | 0.100 |
Why?
| Wnt1 Protein | 1 | 2012 | 10 | 0.100 |
Why?
| Aged, 80 and over | 5 | 2020 | 3392 | 0.100 |
Why?
| Mammary Neoplasms, Animal | 1 | 2012 | 35 | 0.100 |
Why?
| Phytotherapy | 1 | 2012 | 45 | 0.100 |
Why?
| Cadherins | 3 | 2016 | 62 | 0.100 |
Why?
| Interleukin-8 | 2 | 2010 | 86 | 0.100 |
Why?
| Carrier Proteins | 1 | 2014 | 313 | 0.100 |
Why?
| Athletes | 2 | 2023 | 104 | 0.100 |
Why?
| Chick Embryo | 5 | 1999 | 81 | 0.100 |
Why?
| Serine Proteinase Inhibitors | 1 | 2012 | 12 | 0.100 |
Why?
| Aged | 8 | 2023 | 10121 | 0.090 |
Why?
| Organ Specificity | 1 | 2012 | 115 | 0.090 |
Why?
| Rats | 3 | 2023 | 3220 | 0.090 |
Why?
| Microscopy, Phase-Contrast | 1 | 2010 | 13 | 0.090 |
Why?
| Plant Lectins | 1 | 2010 | 8 | 0.090 |
Why?
| PAX2 Transcription Factor | 1 | 2010 | 24 | 0.090 |
Why?
| Cell Line | 2 | 2015 | 1030 | 0.090 |
Why?
| Culture Media, Conditioned | 1 | 2010 | 47 | 0.090 |
Why?
| Prenatal Exposure Delayed Effects | 1 | 2012 | 197 | 0.090 |
Why?
| Carcinoma, Papillary | 1 | 2010 | 51 | 0.090 |
Why?
| Glycosylation | 1 | 2010 | 106 | 0.080 |
Why?
| Substrate Specificity | 1 | 2010 | 193 | 0.080 |
Why?
| Insulin | 1 | 2012 | 479 | 0.080 |
Why?
| Reproducibility of Results | 2 | 2023 | 1229 | 0.080 |
Why?
| Carcinoma, Renal Cell | 1 | 2010 | 111 | 0.080 |
Why?
| Time Factors | 4 | 2017 | 2968 | 0.080 |
Why?
| Magnetics | 1 | 2009 | 34 | 0.080 |
Why?
| Acoustics | 1 | 2009 | 34 | 0.080 |
Why?
| Light | 1 | 2009 | 73 | 0.080 |
Why?
| Analgesics, Opioid | 1 | 2015 | 590 | 0.080 |
Why?
| Phosphopeptides | 1 | 2009 | 7 | 0.080 |
Why?
| Substance-Related Disorders | 1 | 2015 | 609 | 0.080 |
Why?
| Middle Aged | 8 | 2020 | 13028 | 0.080 |
Why?
| Sequence Deletion | 1 | 2009 | 73 | 0.080 |
Why?
| Kidney Neoplasms | 1 | 2010 | 182 | 0.080 |
Why?
| Culture Media | 1 | 2009 | 98 | 0.080 |
Why?
| Neoplastic Cells, Circulating | 1 | 2009 | 74 | 0.080 |
Why?
| Neoplasm Staging | 3 | 2016 | 772 | 0.080 |
Why?
| DNA, Superhelical | 1 | 2008 | 4 | 0.080 |
Why?
| DNA Topoisomerases, Type I | 1 | 2008 | 3 | 0.080 |
Why?
| Salts | 1 | 2008 | 7 | 0.080 |
Why?
| Plasmids | 1 | 2009 | 163 | 0.080 |
Why?
| Protein Structure, Tertiary | 3 | 2005 | 242 | 0.080 |
Why?
| Replication Origin | 1 | 2008 | 11 | 0.080 |
Why?
| Amino Acid Motifs | 1 | 2008 | 57 | 0.080 |
Why?
| Antibodies | 1 | 2009 | 159 | 0.070 |
Why?
| Diet | 1 | 2012 | 587 | 0.070 |
Why?
| Mesoderm | 1 | 2008 | 27 | 0.070 |
Why?
| Escherichia coli | 1 | 2009 | 192 | 0.070 |
Why?
| Polymerase Chain Reaction | 1 | 2009 | 461 | 0.070 |
Why?
| Muscle, Smooth | 1 | 1987 | 64 | 0.070 |
Why?
| Early Detection of Cancer | 1 | 2009 | 189 | 0.070 |
Why?
| Intracellular Signaling Peptides and Proteins | 2 | 2021 | 134 | 0.070 |
Why?
| Disease Models, Animal | 2 | 2021 | 1478 | 0.070 |
Why?
| Integrins | 3 | 2016 | 31 | 0.070 |
Why?
| Protein Binding | 2 | 2008 | 667 | 0.070 |
Why?
| DNA, Mitochondrial | 1 | 2008 | 114 | 0.070 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 582 | 0.070 |
Why?
| Glycoproteins | 1 | 1987 | 122 | 0.070 |
Why?
| Mutation | 2 | 2019 | 1347 | 0.070 |
Why?
| Epithelial Cells | 1 | 2008 | 215 | 0.070 |
Why?
| Breast | 2 | 2016 | 85 | 0.070 |
Why?
| Treatment Outcome | 4 | 2020 | 5422 | 0.070 |
Why?
| Blotting, Western | 3 | 2012 | 590 | 0.060 |
Why?
| DNA, Complementary | 2 | 2004 | 135 | 0.060 |
Why?
| Dimerization | 1 | 2006 | 51 | 0.060 |
Why?
| Lymphatic Metastasis | 2 | 2015 | 220 | 0.060 |
Why?
| E-Selectin | 1 | 2005 | 13 | 0.060 |
Why?
| Pancreatic Neoplasms | 1 | 2008 | 216 | 0.060 |
Why?
| Metals | 1 | 2005 | 36 | 0.060 |
Why?
| Phototherapy | 1 | 2005 | 42 | 0.060 |
Why?
| Chi-Square Distribution | 2 | 2016 | 288 | 0.060 |
Why?
| Ligands | 1 | 2005 | 206 | 0.060 |
Why?
| Immunoblotting | 2 | 2003 | 116 | 0.060 |
Why?
| Fungal Proteins | 1 | 2006 | 117 | 0.060 |
Why?
| Carcinogens | 2 | 2005 | 193 | 0.060 |
Why?
| Heparitin Sulfate | 1 | 2004 | 9 | 0.060 |
Why?
| Fibronectins | 2 | 1998 | 37 | 0.060 |
Why?
| Career Choice | 1 | 2006 | 116 | 0.060 |
Why?
| Matrix Metalloproteinase 9 | 3 | 2002 | 87 | 0.060 |
Why?
| Gold | 1 | 2005 | 128 | 0.060 |
Why?
| Growth Substances | 2 | 2003 | 21 | 0.060 |
Why?
| Hyperthermia, Induced | 1 | 2005 | 120 | 0.060 |
Why?
| Antibodies, Monoclonal | 3 | 2023 | 481 | 0.060 |
Why?
| Osteolysis | 1 | 2004 | 75 | 0.050 |
Why?
| Microscopy, Fluorescence | 2 | 2003 | 160 | 0.050 |
Why?
| Optical Imaging | 1 | 2023 | 26 | 0.050 |
Why?
| Microfilament Proteins | 2 | 2020 | 43 | 0.050 |
Why?
| Odds Ratio | 2 | 2015 | 558 | 0.050 |
Why?
| Cells, Cultured | 4 | 2016 | 1567 | 0.050 |
Why?
| Receptors, Lipoprotein | 1 | 2003 | 7 | 0.050 |
Why?
| Gene Deletion | 1 | 2024 | 272 | 0.050 |
Why?
| Lipoproteins, HDL | 1 | 2003 | 18 | 0.050 |
Why?
| Receptors, Immunologic | 1 | 2003 | 39 | 0.050 |
Why?
| Nitric Oxide Synthase | 1 | 2003 | 62 | 0.050 |
Why?
| Vimentin | 2 | 2016 | 32 | 0.050 |
Why?
| Chondroitin Sulfate Proteoglycans | 1 | 2023 | 18 | 0.050 |
Why?
| Blotting, Northern | 1 | 2003 | 106 | 0.050 |
Why?
| Oligonucleotides, Antisense | 1 | 2003 | 30 | 0.050 |
Why?
| Antigens, Tumor-Associated, Carbohydrate | 1 | 2023 | 24 | 0.050 |
Why?
| Indicator Dilution Techniques | 1 | 2022 | 13 | 0.050 |
Why?
| Deuterium Oxide | 1 | 2022 | 10 | 0.050 |
Why?
| Muscle Strength | 1 | 2023 | 130 | 0.050 |
Why?
| Cell Separation | 1 | 2003 | 83 | 0.050 |
Why?
| Cloning, Molecular | 1 | 2003 | 190 | 0.050 |
Why?
| Logistic Models | 2 | 2015 | 925 | 0.050 |
Why?
| Deuterium | 1 | 2022 | 46 | 0.050 |
Why?
| Mesencephalon | 1 | 2022 | 36 | 0.050 |
Why?
| Mucous Membrane | 1 | 2002 | 31 | 0.050 |
Why?
| Models, Genetic | 1 | 2003 | 169 | 0.050 |
Why?
| Molecular Weight | 3 | 1994 | 82 | 0.050 |
Why?
| Rectum | 1 | 2002 | 55 | 0.050 |
Why?
| Oxidopamine | 1 | 2021 | 3 | 0.050 |
Why?
| Telomere-Binding Proteins | 1 | 2021 | 6 | 0.050 |
Why?
| Estradiol | 1 | 2003 | 214 | 0.050 |
Why?
| Tumor Microenvironment | 1 | 2024 | 256 | 0.050 |
Why?
| Up-Regulation | 1 | 2023 | 454 | 0.050 |
Why?
| Bone Marrow | 1 | 2003 | 364 | 0.050 |
Why?
| Rats, Long-Evans | 1 | 2021 | 25 | 0.050 |
Why?
| Telomere | 1 | 2021 | 38 | 0.050 |
Why?
| Dopamine | 1 | 2022 | 173 | 0.050 |
Why?
| Carcinoma | 1 | 2003 | 138 | 0.050 |
Why?
| Endothelium, Vascular | 1 | 2003 | 246 | 0.050 |
Why?
| Self Administration | 1 | 2021 | 91 | 0.050 |
Why?
| Neuronal Plasticity | 1 | 2021 | 45 | 0.050 |
Why?
| Biopsy | 2 | 2015 | 605 | 0.040 |
Why?
| Gene Expression Regulation | 1 | 2005 | 990 | 0.040 |
Why?
| Retrospective Studies | 3 | 2020 | 6607 | 0.040 |
Why?
| Neuroprotective Agents | 1 | 2021 | 101 | 0.040 |
Why?
| Saccharomyces cerevisiae | 1 | 2021 | 176 | 0.040 |
Why?
| Australia | 1 | 2020 | 89 | 0.040 |
Why?
| Repressor Proteins | 1 | 2021 | 155 | 0.040 |
Why?
| Actin Depolymerizing Factors | 1 | 2020 | 5 | 0.040 |
Why?
| Thiazolidines | 1 | 2020 | 5 | 0.040 |
Why?
| Flow Cytometry | 1 | 2003 | 478 | 0.040 |
Why?
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2020 | 17 | 0.040 |
Why?
| Propensity Score | 1 | 2020 | 154 | 0.040 |
Why?
| Collagen | 2 | 1998 | 211 | 0.040 |
Why?
| Stress Fibers | 1 | 2019 | 5 | 0.040 |
Why?
| HEK293 Cells | 1 | 2020 | 229 | 0.040 |
Why?
| Focal Adhesion Kinase 1 | 1 | 2019 | 14 | 0.040 |
Why?
| HeLa Cells | 1 | 2020 | 265 | 0.040 |
Why?
| Mitogen-Activated Protein Kinase 3 | 1 | 2019 | 49 | 0.040 |
Why?
| Mitogen-Activated Protein Kinase 1 | 1 | 2019 | 50 | 0.040 |
Why?
| Platelet-Derived Growth Factor | 1 | 2019 | 23 | 0.040 |
Why?
| Evaluation Studies as Topic | 1 | 1999 | 105 | 0.040 |
Why?
| Bone Remodeling | 1 | 2000 | 155 | 0.040 |
Why?
| Pseudopodia | 1 | 1998 | 5 | 0.040 |
Why?
| Prostatic Neoplasms | 1 | 2002 | 398 | 0.040 |
Why?
| Gene Expression Profiling | 1 | 2003 | 1105 | 0.040 |
Why?
| RNA, Small Interfering | 1 | 2019 | 213 | 0.040 |
Why?
| Thiophenes | 1 | 1998 | 38 | 0.040 |
Why?
| Linear Models | 1 | 1999 | 287 | 0.040 |
Why?
| Dose-Response Relationship, Drug | 1 | 2021 | 1378 | 0.040 |
Why?
| Survival Rate | 1 | 2020 | 945 | 0.040 |
Why?
| Phenylalanine | 1 | 1998 | 132 | 0.040 |
Why?
| Databases, Factual | 1 | 2020 | 706 | 0.030 |
Why?
| Antineoplastic Agents | 1 | 2005 | 1222 | 0.030 |
Why?
| Hematocrit | 1 | 2017 | 44 | 0.030 |
Why?
| Blood Urea Nitrogen | 1 | 2017 | 42 | 0.030 |
Why?
| Infant, Newborn | 1 | 2024 | 2867 | 0.030 |
Why?
| Mice, Knockout | 2 | 2014 | 879 | 0.030 |
Why?
| Creatinine | 1 | 2017 | 150 | 0.030 |
Why?
| Risk Factors | 2 | 2015 | 3889 | 0.030 |
Why?
| Systemic Inflammatory Response Syndrome | 1 | 2017 | 67 | 0.030 |
Why?
| Lymph Nodes | 1 | 1998 | 258 | 0.030 |
Why?
| Abdominal Pain | 1 | 2017 | 85 | 0.030 |
Why?
| Enzyme Inhibitors | 1 | 1998 | 372 | 0.030 |
Why?
| Pain Measurement | 1 | 2017 | 256 | 0.030 |
Why?
| Acute Disease | 1 | 2017 | 373 | 0.030 |
Why?
| Anion Exchange Protein 1, Erythrocyte | 1 | 2015 | 8 | 0.030 |
Why?
| Antiporters | 1 | 2015 | 19 | 0.030 |
Why?
| beta Catenin | 1 | 2016 | 102 | 0.030 |
Why?
| S100 Proteins | 1 | 2015 | 34 | 0.030 |
Why?
| Mice, Inbred C57BL | 2 | 2016 | 1884 | 0.030 |
Why?
| Antigens, CD | 1 | 2016 | 218 | 0.030 |
Why?
| Professional Role | 1 | 2015 | 78 | 0.030 |
Why?
| Common Variable Immunodeficiency | 1 | 2014 | 8 | 0.030 |
Why?
| GTPase-Activating Proteins | 1 | 2014 | 25 | 0.030 |
Why?
| Neoplasm, Residual | 1 | 2015 | 173 | 0.030 |
Why?
| Down-Regulation | 1 | 2015 | 346 | 0.030 |
Why?
| Multivariate Analysis | 1 | 2015 | 591 | 0.030 |
Why?
| Protease Inhibitors | 1 | 1994 | 61 | 0.030 |
Why?
| Pharmacists | 1 | 2015 | 144 | 0.030 |
Why?
| Interleukin-1beta | 1 | 2014 | 86 | 0.030 |
Why?
| Ubiquitin-Protein Ligases | 1 | 2014 | 96 | 0.030 |
Why?
| Severity of Illness Index | 1 | 2017 | 1026 | 0.030 |
Why?
| Patient-Centered Care | 1 | 2015 | 141 | 0.030 |
Why?
| Lipopolysaccharides | 1 | 2014 | 206 | 0.030 |
Why?
| NF-kappa B | 1 | 2014 | 322 | 0.020 |
Why?
| Immunoenzyme Techniques | 1 | 2012 | 137 | 0.020 |
Why?
| Lactation | 1 | 2012 | 60 | 0.020 |
Why?
| Disease Progression | 1 | 2015 | 871 | 0.020 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 185 | 0.020 |
Why?
| Adolescent | 1 | 2023 | 6739 | 0.020 |
Why?
| Cell Nucleus | 2 | 2010 | 187 | 0.020 |
Why?
| Melanoma | 1 | 1994 | 288 | 0.020 |
Why?
| Mice, Transgenic | 1 | 2012 | 552 | 0.020 |
Why?
| Cross Reactions | 2 | 1987 | 41 | 0.020 |
Why?
| Rheology | 1 | 2009 | 7 | 0.020 |
Why?
| Molecular Mimicry | 1 | 2009 | 38 | 0.020 |
Why?
| Matrix Metalloproteinase 2 | 2 | 2002 | 56 | 0.020 |
Why?
| Receptors, Transforming Growth Factor beta | 1 | 2008 | 29 | 0.020 |
Why?
| Sensitivity and Specificity | 1 | 2010 | 891 | 0.020 |
Why?
| Nanoparticles | 1 | 2009 | 160 | 0.020 |
Why?
| Predictive Value of Tests | 1 | 2010 | 944 | 0.020 |
Why?
| Microscopy, Electron | 1 | 1987 | 75 | 0.020 |
Why?
| Transforming Growth Factor beta | 1 | 2008 | 138 | 0.020 |
Why?
| Chickens | 1 | 1987 | 107 | 0.020 |
Why?
| Diagnosis, Differential | 1 | 2010 | 1046 | 0.020 |
Why?
| Fibroblast Growth Factor 2 | 1 | 2005 | 34 | 0.020 |
Why?
| Kidney | 1 | 2010 | 707 | 0.020 |
Why?
| Pregnancy | 1 | 2012 | 2680 | 0.010 |
Why?
| Vascular Endothelial Growth Factor A | 1 | 2005 | 182 | 0.010 |
Why?
| Scavenger Receptors, Class B | 1 | 2003 | 10 | 0.010 |
Why?
| Hormone Replacement Therapy | 1 | 2003 | 21 | 0.010 |
Why?
| Nitric Oxide Synthase Type II | 1 | 2003 | 62 | 0.010 |
Why?
| Receptors, Scavenger | 1 | 2003 | 29 | 0.010 |
Why?
| Ovariectomy | 1 | 2003 | 113 | 0.010 |
Why?
| Spectrin | 1 | 1982 | 3 | 0.010 |
Why?
| Nitric Oxide Synthase Type III | 1 | 2003 | 78 | 0.010 |
Why?
| Brain Chemistry | 1 | 1982 | 68 | 0.010 |
Why?
| Vasodilation | 1 | 2003 | 99 | 0.010 |
Why?
| Femoral Artery | 1 | 2003 | 103 | 0.010 |
Why?
| Protein Transport | 1 | 2003 | 180 | 0.010 |
Why?
| Endoscopy | 1 | 2002 | 123 | 0.010 |
Why?
| Neutrophils | 1 | 2002 | 147 | 0.010 |
Why?
| Sex Factors | 1 | 2003 | 727 | 0.010 |
Why?
| beta 2-Microglobulin | 1 | 1997 | 39 | 0.010 |
Why?
| Rhodamines | 1 | 1993 | 5 | 0.010 |
Why?
| Cell Adhesion Molecules | 1 | 1994 | 86 | 0.010 |
Why?
| Tissue Inhibitor of Metalloproteinase-2 | 1 | 1993 | 12 | 0.010 |
Why?
| Gelatin | 1 | 1993 | 22 | 0.010 |
Why?
| Biotin | 1 | 1993 | 46 | 0.010 |
Why?
| Binding Sites | 1 | 1993 | 377 | 0.010 |
Why?
| Amino Acid Sequence | 1 | 1993 | 578 | 0.010 |
Why?
| Molecular Sequence Data | 1 | 1993 | 778 | 0.010 |
Why?
| Talin | 1 | 1989 | 3 | 0.010 |
Why?
| Concanavalin A | 1 | 1989 | 11 | 0.010 |
Why?
| Microspheres | 1 | 1989 | 21 | 0.010 |
Why?
| Cell Line, Transformed | 1 | 1989 | 74 | 0.010 |
Why?
| Vinculin | 1 | 1982 | 3 | 0.000 |
Why?
| Immune Sera | 1 | 1982 | 15 | 0.000 |
Why?
| Actinin | 1 | 1982 | 3 | 0.000 |
Why?
| Erythrocyte Membrane | 1 | 1982 | 14 | 0.000 |
Why?
| Ankyrins | 1 | 1982 | 9 | 0.000 |
Why?
| Electrophoresis, Polyacrylamide Gel | 1 | 1982 | 96 | 0.000 |
Why?
| Fluorescent Antibody Technique | 1 | 1982 | 111 | 0.000 |
Why?
| Epitopes | 1 | 1982 | 65 | 0.000 |
Why?
| Cattle | 1 | 1982 | 205 | 0.000 |
Why?
| Terminology as Topic | 1 | 1982 | 70 | 0.000 |
Why?
| Swine | 1 | 1982 | 428 | 0.000 |
Why?
| Muscle Proteins | 1 | 1982 | 321 | 0.000 |
Why?
|
|
Kelly Jr's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|